Try it
Psychiatry · Antipsychotics: quetiapine
Sample itemWhich atypical antipsychotic has approval for both acute mania and bipolar depression, and carries low EPS risk but marked sedation and weight gain?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Quetiapine
Quetiapine is licensed for schizophrenia, bipolar mania and bipolar depression. It has weak D2 binding and high H1 affinity, explaining the sedation and low EPS.
Option by option
A. Risperidone
Risperidone is used for mania and psychosis but not approved for bipolar depression.
B. Haloperidol
Haloperidol is used for mania but not bipolar depression and carries high EPS.
C. Amisulpride
Amisulpride is used in schizophrenia and dysthymia at low doses.
D. Quetiapine (correct)
Correct. Quetiapine is used across bipolar phases.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Psychiatry questions
- PsychopharmacologyLithium use during the first trimester of pregnancy is associated with which congenital…
- Psychotic disordersWhich of the following is a Schneiderian first-rank symptom of schizophrenia?
- Organic psychiatryAn elderly patient on a surgical ward develops acute confusion that fluctuates through t…
- Eating disordersA 17-year-old girl has a BMI of 15, amenorrhoea, lanugo hair, bradycardia and an intense…